Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine and Bifidobacterium in Type 2 Diabetes
NCT02084004Phase 3Withdrawn
- Sponsor
- Xijing Hospital
- Start
- Nov 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of berberine, Golden Bifid in type 2 diabetes mellitus (T2DM), sponsored by Xijing Hospital. Planned start Nov 2015; status: withdrawn.
02
Drugs
berberineGolden Bifid
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02084004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084004.